In order to obtain this action we must pay 2,49$ right now, In this post we are going to talk about the listed company Lixte Biotechnology Holdings Inc, its leaders are James S. Miser (Chief Medical Officer), John S. Kovach (Chairman, President & Chief Executive Officer), Robert N. Weingarten (Chief Financial Officer & Vice President), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 2,47$ moving between 2,44$ and 2,50$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
